Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS.

Although the number of days IBS symptoms interfered with household activities was reduced, the treatment differences did not reach statistical significance compared with placebo ( Figure 3 b).

also in 111,027 other papers